Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: 15 - You Need To See This

Pfizer’s COVID cash powers a ‘marketing machine’ on the hunt for new supernovas

For drugmaker Pfizer, a fortune amassed in the COVID pandemic is now paving the path to pharma nirvana: a weight loss pill worth billions.

Tribune News Service

Vulnerable Australians want access to another booster dose. Here's the state of play across the country

As COVID cases rise across the country, there are calls for additional booster doses to be made available to Australians who want it.

ABC News

Pfizer is on the hunt for new blockbuster drugs, backed by its COVID fortune

While sales of its COVID vaccines are falling, Pfizer plans to triple the price of the shots and use its bonanza from government contracts to buy and develop new blockbusters.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Gold Drops Over 1%; Moderna Reports Downbeat Q3 Results

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping over 100 points on Thursday.

Benzinga

The ProPublica-Vanity Fair report on Covid’s origins is explosive. Is it reliable?

Critics say the article is flawed. But that shouldn’t discredit the lab leak theory

The Guardian - US

This Is What Whales Are Betting On Moderna

Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

PepsiCo, Walmart And 2 Other Stocks Insiders Are Selling

The Nasdaq Composite gained by over 300 points on Friday. Investors, meanwhile, focused on some notable insider trades.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Moderna Unusual Options Activity

A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 17 strange trades.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022

Upgrades

Benzinga

As links to MS deepen, researchers accelerate efforts to develop an Epstein-Barr vaccine

Maybe you’ve never heard of the Epstein-Barr virus. But it knows all about you.

Tribune News Service

Moderna jab ‘to protect through the winter’ after positive new results

The main Covid-19 booster offers good protection for at least three months.

The Independent UK

Updated Moderna Covid booster gives even better protection than earlier jab

Biotech firm’s data shows stronger immune response to Omicron than original vaccine three months after being given

The Guardian - UK

Covid winter boosters, new vaccines and why side effects may be different

Everybody over 50 is invited for a winter coronavirus jab but not everybody will get the new dual/bivalent vaccines that target multiple strains

Chronicle Live

Moderna to supply 100 million COVID vaccines to poor countries

Moderna Inc. will provide as many as 100 million doses of COVID-19 shots that specifically target variants for vaccine alliance Gavi to distribute in lower-income countries in 2023.

Tribune News Service

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Check Out What Whales Are Doing With MRNA

Asharq Al-Awsat

Moderna Signs Deal on Variant-Adapted COVID Shots for World’s Poorest

Moderna Inc has agreed to provide its new variant-adapted COVID-19 vaccine to the global scheme aiming to deliver shots to the world's poorest people. The biotech company and vaccine alliance GAVI will cancel their existing supply deal for vaccines based on the original coronavirus strain. Instead, Moderna will supply up…

ABC News

What vaccine can you get, based on your age? These are the recommended COVID-19 vaccines for each age group

More than 14.2 million Australians over the age of 16 have now received three or more doses. So which are the best vaccines for each age group?

Daily Mirror

Breakthrough cancer vaccine could be ready in months, say scientists

Manufacturers Moderna and Merck are testing a breakthrough cancer vaccine for patients suffering from melanoma which kills thousands of people each year in the UK

Get all your
news in one place.

100's of premium titles.
One news app.

Radio France Internationale

How Western countries could stop Africa making vaccines of the future

While Western donors have stumped up significant funding for a programme to make Covid-19 vaccines in Africa, activists say more support is needed to help poor countries secure the intellectual property rights they need to produce mRNA vaccines beyond the pandemic.

Salon

Fla. surgeon general's anti-vax warning

"This study is too flawed to be used to set policy on the mRNA vaccines in younger males," one expert said

Benzinga

Check Out What Whales Are Doing With MRNA

A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 26 strange trades.

Benzinga

Why Norwegian Cruise Line Shares Climbed By Around 12%; Here Are 66 Biggest Movers From Yesterday

Gainers Pintec Technology Holdings Limited (NASDAQ: PT) shares jumped 216.2% to close at $0.9058 on Wednesday.

Benzinga

Moderna Rallies On Merck Collaboration: Can Drugmaker Replace COVID Vaccine Revenue?

In late 2020, when the world was searching for a vaccine or cure for COVID-19, the price action in Moderna Inc (NASDAQ: MRNA) was discussed frequently on Benzinga's PreMarket Prep show.

Tribune News Service

FDA authorizes COVID omicron boosters for kids 5 and up

COVID-19 vaccine makers Pfizer Inc. and Moderna Inc. received U.S. regulatory clearances for their omicron-targeted boosters for children as young as 5.

Benzinga

Why T2 Biosystems Shares Are Trading Lower By Over 28%, Here Are 41 Stocks Moving In Wednesday's Mid-Day Session

Gainers Code Chain New Continent Limited (NYSE: CCNC) shares jumped 74% to $0.2868 after declining around 14% on Tuesday.

1 … 14 15 16 17

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Intellectual Property

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.